SynthesisFrontiers in cardiovascular medicine2025
A systematic review and network meta-analysis of cardiovascular safety of benzbromarone compared to febuxostat and allopurinol in patients with gout.
Ting-Syuan Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.